ABVC BioPharma Inc【ABVC】 業績推移・財務諸表

(単位:千ドル) 1Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 1Q16 3Q16 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25
現金同等物 30 13 2 0 0 0 - 0 0 - 0 0 2 - - 204 5 57 4 40 981 540 1,051 160 139 406 151 5,001 3,333 1,657 4,449 6,565 3,432 3,599 1,970 1,391 1,791 742 1,120 716 659 742 769 863 759
有価証券 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 111 108 95 82 77 75 78 76 68 79 75 75 70 64 65
現金 + 有価証券 30 13 2 0 0 0 - 0 0 - 0 0 2 - - 204 5 57 4 40 981 540 1,051 160 139 406 151 5,001 3,333 1,657 4,561 6,673 3,528 3,682 2,047 1,467 1,869 818 1,189 796 734 818 840 928 824
売掛金 - - 1 1 1 1 1 1 1 0 0 0 0 - - - - - - - - - - - - - - - 392 297 331 280 281 289 47 98 124 12 1 1 1 1 1 - -
商品及び製品 - - - - - - - - - 0 0 0 0 0 - - - - - - 0 0 - - - - - - - - 60 25 22 21 20 - - - - - - - - - 11
流動資産合計 52 48 25 13 1 1 1 1 1 0 0 0 2 0 3,584 2,754 2,555 2,649 2,594 96 1,527 1,234 1,707 878 802 1,604 1,177 6,172 5,205 3,627 7,111 9,625 7,987 9,789 2,903 2,987 3,480 2,128 2,493 1,656 1,794 2,189 2,148 2,179 1,469
有形固定資産 56 46 43 40 37 37 37 37 37 0 0 0 0 - - - - - - - 547 528 514 520 505 507 506 514 504 511 527 525 598 597 566 573 571 564 7,953 7,969 7,949 7,929 7,931 511 8,168
投資有価証券 - - - - - - - - - - - - - - - - - - - - 3,407 3,335 3,270 3,364 3,264 2,196 1,192 1,190 1,126 1,095 1,006 932 904 870 816 842 849 831 2,677 2,527 2,474 2,377 2,333 2,258 2,760
固定資産合計 276 253 246 238 230 230 230 230 230 64 64 64 64 64 3 0 0 0 0 0 5,923 5,906 5,697 6,049 5,862 4,827 5,351 5,433 5,320 5,317 5,243 4,072 4,078 3,993 7,577 6,868 7,254 7,191 14,097 12,835 12,665 12,444 12,314 5,360 13,406
総資産 329 302 271 251 231 231 231 231 231 64 64 64 67 64 3,588 2,754 2,555 2,649 2,594 96 7,450 7,140 7,404 6,927 6,665 6,432 6,529 11,606 10,526 8,944 12,354 13,698 12,066 13,782 10,480 9,855 10,734 9,320 16,591 14,492 14,460 14,633 14,462 7,539 14,875
買掛金 40 - - - - - - - - - - - - - 11 - - - - - 15 19 13 23 20 7 23 23 10 5 16 - - 2 - - - - - - - - - - -
流動負債合計 1,677 1,946 2,066 2,092 - 2,112 - - - 34 35 35 37 - - - - 4,333 4,478 5,568 12,435 10,107 5,877 6,814 7,654 7,574 6,045 4,844 4,666 4,376 3,438 3,692 3,663 3,645 3,894 5,819 5,074 5,772 5,363 5,932 6,633 6,548 6,315 6,557 6,730
長期借入金 - - - - - - - - - - - - - - - - - - - - - - - - - 124 124 - - - - - - - - - - - - - - - - - -
固定負債合計 - - - - - - - - - - - - - - - - - 553 564 277 541 173 796 238 182 302 1,675 4,100 4,131 4,052 1,326 1,135 1,041 956 893 799 3,925 3,914 2,166 429 339 256 167 258 188
総負債 - - - - - - - - - - - - - - 2,061 4,147 4,489 4,887 5,043 5,845 12,976 10,281 6,674 7,052 7,837 7,876 7,721 8,944 8,797 8,428 4,765 4,827 4,705 4,602 4,787 6,619 9,000 9,687 7,529 6,361 6,973 6,805 6,483 6,815 6,919
資本金及び資本剰余金 27,894 28,670 28,670 28,670 28,670 54 28,670 28,670 28,670 54 54 54 54 111 2,196 14,002 14,105 14,115 14,123 14,995 15,698 18,706 28,199 28,199 28,242 28,242 29,969 40,776 40,776 41,026 49,744 58,142 62,608 66,272 66,526 67,940 68,081 68,081 80,667 73,986 86,039 87,094 87,320 78,608 83,630
利益剰余金 -29,244 -30,314 -30,472 -30,511 -30,551 -30,551 -30,551 -30,551 -30,551 -25 -26 -26 -25 -47 -354 -15,396 -16,039 -16,354 -16,572 -19,878 -13,002 -13,559 -14,774 -15,852 -17,099 -18,949 -20,795 -25,643 -26,771 -28,743 -30,549 -38,482 -44,477 -46,336 -50,041 -54,905 -56,729 -58,992 -62,310 -65,421 -69,354 -70,366 -70,553 -68,950 -69,792
株主資本 -1,349 -1,644 -1,801 -1,841 -1,881 -1,881 -1,881 -1,881 -1,881 30 29 28 29 64 1,527 -1,394 -1,934 -2,238 -2,449 -5,750 -5,527 -3,142 730 -125 -1,137 -1,074 -537 3,438 2,571 1,440 8,593 8,870 7,426 9,334 5,918 3,236 1,734 -368 9,099 8,388 7,792 8,293 8,358 1,226 7,956
有利子負債合計 - - - - - - - - - - - - - - - - - - - - - - - - - 124 124 - - - - - - - - - - - - - - - - - -
純有利子負債 - - - - - - - - - - - - - - - - - - - - - - - - - -282 -28 - - - - - - - - - - - - - - - - - -
DEレシオ(%) - - - - - - - - - - - - - - - - - - - - - - - - - -11.59 -23.19 - - - - - - - - - - - - - - - - - -
運転資本 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -